ALDH, GRP-75 and DRP-2 disclosed mild positivity with respectively 4%, 4% and 6% of the GBM samples exhibiting an increase in mRNA expression more than 2-fold greater than the reference. This evidence concerns the gene LDHA and glioblastoma.